Polar Capital’s Tobira Therapeutics, Inc. Common Stock TBRA Stock Holding History

Polar Capital’s Portfolio TBRA Stock Details TBRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q2	–	Sell	-50,000	Closed	-$409K	–	290
2016 Q1	$409K	Buy	50,000 +15,939	+47%	+$120K	0.01%	253
2015 Q4	$342K	Sell	34,061 -33,509	-50%	-$348K	0.01%	256
2015 Q3	$653K	Buy	67,570 +33,510	+98%	+$470K	0.01%	252
2015 Q2	$588K	Buy	34,060 +9,060	+36%	+$132K	0.01%	267
2015 Q1	$275K	Buy	+25,000	New	+$268K	0.01%	276

Other funds holding TBRA

Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

NHAS

Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $250M AUM 77.6% 1-Year Est. Return

Abingworth London, United Kingdom $307M AUM 93.47% 1-Year Est. Return

BB Biotech Schaffhausen, Switzerland $3.98B AUM 15.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Axa Paris, France $256M AUM 25.01% 1-Year Est. Return

Polar Capital's TBRA Position: Q2 2016 in Review

Polar Capital sold out of Tobira Therapeutics, Inc. Common Stock (TBRA) in Q2 2016, closing a stake of 50,000 shares — an estimated $409K sold.

Polar Capital first reported a position in TBRA in Q1 2015 and held it in 5 quarters. The position peaked at $653K in Q3 2015. 45 funds tracked by Wall St. Rank hold TBRA as of Q2 2016.

Polar Capital reported no remaining Tobira Therapeutics, Inc. Common Stock position as of Q2 2016 after selling out during the quarter.
Polar Capital sold 50,000 Tobira Therapeutics, Inc. Common Stock shares in Q2 2016, an estimated $409K.
Polar Capital first reported a position in Tobira Therapeutics, Inc. Common Stock in Q1 2015 and held it in 5 quarters.
Polar Capital's Tobira Therapeutics, Inc. Common Stock position peaked at $653K in Q3 2015.
45 funds tracked by Wall St. Rank held Tobira Therapeutics, Inc. Common Stock as of Q2 2016.

Based on Polar Capital's 13F filing for Q2 2016, filed 15 Aug 2016.